Copyright
©The Author(s) 2022.
World J Clin Oncol. Feb 24, 2022; 13(2): 135-146
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.135
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.135
Figure 3 Percentage of mutations in the most common breast cancer associated genes in breast cancers with and without neurotrophic receptor tyrosine kinase amplifications.
Data are from TCGA breast cancer cohort. Black columns: Neurotrophic receptor tyrosine kinase amplified; Grey columns: Neurotrophic receptor tyrosine kinase non-amplified.
- Citation: Stravodimou A, Voutsadakis IA. Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas. World J Clin Oncol 2022; 13(2): 135-146
- URL: https://www.wjgnet.com/2218-4333/full/v13/i2/135.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i2.135